DRN vs. CURE
DRN (Direxion Daily Real Estate Bull 3x Shares) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - DRN is a REIT fund tracking the MSCI US REIT Index (300%), while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, DRN returned -5.10%/yr vs 11.41%/yr for CURE. A 0.51 correlation means they provide meaningful diversification when combined. DRN charges 0.99%/yr vs 1.08%/yr for CURE.
Performance
DRN vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DRN achieves a 19.36% return, which is significantly higher than CURE's -20.11% return. Over the past 10 years, DRN has underperformed CURE with an annualized return of -5.10%, while CURE has yielded a comparatively higher 11.41% annualized return.
DRN
- 1D
- 1.30%
- 1M
- -6.56%
- YTD
- 19.36%
- 6M
- 16.51%
- 1Y
- 6.60%
- 3Y*
- 7.32%
- 5Y*
- -11.56%
- 10Y*
- -5.10%
CURE
- 1D
- -2.92%
- 1M
- 1.15%
- YTD
- -20.11%
- 6M
- -19.30%
- 1Y
- 19.67%
- 3Y*
- -0.86%
- 5Y*
- -0.04%
- 10Y*
- 11.41%
DRN vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DRN Direxion Daily Real Estate Bull 3x Shares | 19.36% | -11.24% | -5.29% | 12.03% | -67.26% | 152.94% | -55.37% | 81.86% | -25.11% | 7.50% |
CURE Direxion Daily Healthcare Bull 3x Shares | -20.11% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between DRN and CURE is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.59 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2011 | 0.51 |
The correlation between DRN and CURE shifts across timeframes, from 0.43 (1 year) to 0.59 (5 years), reflecting how their relationship changes across market environments.
DRN vs. CURE - Sectors Allocation Comparison
Sectors
DRN
CURE
Real Estate
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Healthcare
-
Industrials
-
-
Technology
-
-
Utilities
-
-
Real Estate
DRN
CURE
-
Basic Materials
DRN
CURE
-
Communication Services
DRN
-
CURE
-
Consumer Cyclical
DRN
-
CURE
-
Consumer Defensive
DRN
-
CURE
-
Energy
DRN
-
CURE
-
Financial Services
DRN
-
CURE
-
Healthcare
DRN
-
CURE
Industrials
DRN
-
CURE
-
Technology
DRN
-
CURE
-
Utilities
DRN
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRN vs. CURE — Risk / Return Rank
DRN
CURE
DRN vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Real Estate Bull 3x Shares (DRN) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DRN | CURE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.17 | 0.46 | -0.29 |
Sortino ratioReturn per unit of downside risk | 0.50 | 0.98 | -0.48 |
Omega ratioGain probability vs. loss probability | 1.06 | 1.11 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.29 | 0.64 | -0.35 |
Martin ratioReturn relative to average drawdown | 0.65 | 1.49 | -0.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DRN | CURE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.17 | 0.46 | -0.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.20 | -0.00 | -0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.08 | 0.23 | -0.32 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.46 | -0.25 |
Drawdowns
DRN vs. CURE - Drawdown Comparison
The maximum DRN drawdown since its inception was -86.32%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for DRN and CURE.
Loading charts...
Drawdown Indicators
| DRN | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.32% | -69.19% | -17.13% |
Max Drawdown (1Y)Largest decline over 1 year | -24.28% | -31.10% | +6.82% |
Max Drawdown (3Y)Largest decline over 3 years | -48.26% | -51.93% | +3.67% |
Max Drawdown (5Y)Largest decline over 5 years | -80.58% | -52.23% | -28.35% |
Max Drawdown (10Y)Largest decline over 10 years | -86.32% | -69.19% | -17.13% |
Current DrawdownCurrent decline from peak | -65.97% | -36.59% | -29.38% |
Average DrawdownAverage peak-to-trough decline | -35.06% | -18.14% | -16.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.89% | 13.34% | -2.45% |
Volatility
DRN vs. CURE - Volatility Comparison
The current volatility for Direxion Daily Real Estate Bull 3x Shares (DRN) is 11.21%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 11.87%. This indicates that DRN experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRN | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 11.87% | -0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 29.18% | 30.02% | -0.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.04% | 43.14% | -3.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.66% | 43.68% | +12.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.62% | 49.51% | +11.11% |
DRN vs. CURE - Expense Ratio Comparison
DRN has a 0.99% expense ratio, which is lower than CURE's 1.08% expense ratio.
Dividends
DRN vs. CURE - Dividend Comparison
DRN's dividend yield for the trailing twelve months is around 2.23%, more than CURE's 1.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.34% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
DRN Direxion Daily Real Estate Bull 3x Shares | 2.23% | 2.81% | 2.24% | 2.84% | 2.70% | 4.21% | 1.90% | 2.59% | 3.11% | 0.91% |
Frequently Asked Questions
DRN and CURE have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (11.87%) compared to DRN (11.21%). In terms of maximum drawdown, DRN dropped -86.32% vs CURE's -69.19%.
On 10-year performance, CURE leads with 11.41% vs -5.10% for DRN. On fees, DRN is cheaper at 0.99% per year. On volatility, DRN has been the lower-risk option at 11.21%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 11.41% return vs -5.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DRN is cheaper with a 0.99% expense ratio, compared with 1.08% for CURE.
DRN has the higher dividend yield at 2.23%, compared with 1.34% for CURE.
DRN is categorized as REIT, while CURE is Leveraged Equities. DRN tracks MSCI US REIT Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 0.99% for DRN and 1.08% for CURE.
CURE currently has the higher Sharpe Ratio (0.46 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DRN and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer